Elmar R. Burchardt
- Hepatology top 1%
- Liver physiology and pathology 5
- Genetics top 5%
- Mesenchymal stem cell research 5
- Epidemiology top 10%
- Liver Disease Diagnosis and Treatment 3
- Surgery top 10%
- Tissue Engineering and Regenerative Medicine 3
- Pharmacology top 10%
-
- Cell Adhesion Molecules Research 4
-
- Protease and Inhibitor Mechanisms 3
-
- Angiogenesis and VEGF in Cancer 3
-
- Blood transfusion and management 2
- Co-authors
- Branko StefanovicDavid A. BrennerClaus HellerbrandFrank J. GiordanoRichard A. RippeTim WaterboerJeffrey N. LindquistSung Kyu Choi
- Cited by
- HepatologyGeneticsEpidemiology
- Partner nations
- GermanyUnited StatesIsrael
In The Last Decade
Elmar R. Burchardt
21 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 74
- Hepatology 630
- Genetics 174
- Epidemiology 442
- Surgery 381
- Pharmacology 73
Countries citing papers authored by Elmar R. Burchardt
This map shows the geographic impact of Elmar R. Burchardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elmar R. Burchardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elmar R. Burchardt more than expected).
Fields of papers citing papers by Elmar R. Burchardt
This network shows the impact of papers produced by Elmar R. Burchardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elmar R. Burchardt. The network helps show where Elmar R. Burchardt may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Elmar R. Burchardt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 4 | |
| 2 | 2021 | 7 | |
| 3 | 2011 | 1 | |
| 4 | 2010 | 23 | |
| 5 | Tissue repair cells for the treatment of cardiovascular diseases | 2007 | 3 |
| 6 | 2006 | 65 | |
| 7 | 2004 | 33 | |
| 8 | 2004 | 27 | |
| 9 | 2003 | 30 | |
| 10 | 2002 | 54 | |
| 11 | 2002 | 20 | |
| 12 | 2001 | 146 | |
| 13 | 2000 | 11 | |
| 14 | 2000 | 164 | |
| 15 | 1999 | 1 | |
| 16 | 1999 | 9 | |
| 17 | 1999 | 331 | |
| 18 | 1998 | 7 | |
| 19 | 1997 | 1 | |
| 20 | Assessment of G-CSF and GM-CSF mRNA expression in peripheral blood mononuclear cells from patients with severe congenital neutropenia and in human myeloid leukemic cell lines. | 1993 | 10 |
About Elmar R. Burchardt
Elmar R. Burchardt is a scholar working on Immunology and Allergy, Hepatology, Genetics, Biochemistry and Cancer Research, having authored 21 papers that have together received 1.1k indexed citations. Recurring topics across this work include Mesenchymal stem cell research (5 papers), Liver physiology and pathology (5 papers), Cell Adhesion Molecules Research (4 papers), Tissue Engineering and Regenerative Medicine (3 papers), Liver Disease Diagnosis and Treatment (3 papers), Protease and Inhibitor Mechanisms (3 papers), Angiogenesis and VEGF in Cancer (3 papers) and Blood transfusion and management (2 papers). The work is most often cited by research in Hepatology (630 citations), Genetics (174 citations), Epidemiology (442 citations), Surgery (381 citations) and Pharmacology (73 citations). Elmar R. Burchardt has collaborated with scholars based in Germany, United States and Israel. Frequent co-authors include Branko Stefanovic, David A. Brenner, Claus Hellerbrand, Frank J. Giordano, Richard A. Rippe, Tim Waterboer, Jeffrey N. Lindquist, Sung Kyu Choi, Ali Ghodsizad and Christoph Piechaczek. Their work appears in journals such as Transfusion, Journal of Hepatology, The Heart Surgery Forum, Prostaglandins Leukotrienes and Essential Fatty Acids and Stem Cells.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.